Myriad Genetics, Inc. (MYGN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Myriad Genetics, Inc. (MYGN)

MYGN 5.545

-6.5%

2:58 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: NeuroInvestment who wrote (1729)	11/28/2005 1:42:08 PM
From: tuck	Read Replies (1) of 2355

Hi, Harry, Good of you to drop by. Pretty much agree with your assessment of Flurizan. I think the market does, too. If only management did (either by dropping it or partnering (but good luck attracting a partner with these results)). Anyhow, I have a small position via sold puts. The reason for that is a) the predictive medicine business that you alluded to, and b) the early stage oncology programs that you did not allude to. There's also the viral budding program, but I need to check this against PA-457, which is farther along, and comparable (I think). Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next